Announcements
Announcement of amendment of the regulations for issuance and subscription of 2021 employee stock options
1.Date of occurrence of the event: 2021/11/05 2.Date of the original announcement and reporting: 2021/08/06 3.Summary of the content originally announced and reported: The Company originally resolved and announced the …
Announcement of the Consolidated Financial Statements for the third quarter of 2021 were authorized for issuance by the Board of Directors
1.Date of the financial reports submitted to the board of directors or approved by the board of directors: 2021/11/05 2.Date of the financial reports approved by the audit committee: 2021/11/05 …
OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities
1.Date of institutional investor conference: 2021/11/11 2.Time of institutional investor conference: 2021/11/11 3.Location of institutional investor conference: Masterlink Securities (Address:No.97-11, Sec. 2, Dunhua S. Rd., Da’an Dist., Taipei City 106, …
Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of Re-election of directors and supervisors at the 2021 annual shareholders’ meeting
1.Date of occurrence of the change:2021/10/27 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor): Institutional director, natural-person director and natural-person supervisor. …
Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. that the Company’s Board of Directors resolved to appoint Ms. Tessie Che as Chairperson
1.Date of the board of directors resolution or date of occurrence of the change: 2021/10/27 2.Position (Please enter chairperson or president/general manager): Chairperson 3.Name of the previous position holder: Tessie …
Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of Resolution to lift the non-competition restrictions for new directors
1.Date of the shareholders’ meeting resolution:2021/10/27 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director Tessie Che Director …
Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of important resolutions of the 2021 annual shareholders’ meeting
1.Date of the shareholders’ meeting:2021/10/27 2.Important resolutions I.Profit distribution/deficit compensation: Acknowledgement of the 2020 Earnings Distribution Loss Off-setting. 3.Important resolutions II.Amendments of the company charter: Approval of the amendments to …
OBI-866 ”Immunogenic/Therapeutic Glycan Compositions And Uses Thereof“ Was Granted By Taiwan Intellectual Property Office
1.Date of occurrence of the event:2021/10/27 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4.Reciprocal shareholding ratios: Not applicable 5.Cause of …
Application of Investigational Device Exemption for Immunohistochemistry applied to Phase II Clinical Trial of OBI-999, has been granted by FDA
1.Date of occurrence of the event:2021/10/25 2.New drug name or code: Immunohistochemistry (IHC) applied to Phase II Cohort Expansion Human Clinical Trial of OBI-999 3.Indication: Application of Investigational Device Exemption …
The Globo H Antibody Drug Conjugate, OBI-999, has been granted by TFDA to proceed to Phase II Human Clinical Study
1.Date of occurrence of the event: October 21, 2021 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4.Reciprocal shareholding ratios: Not …